Thumb Arthritis Market Research Report - Global Forecast till 2027

Thumb Arthritis Market Research Report: By Type (Osteoarthritis, Rheumatoid) Diagnosis (Physical Examinations, Imaging, FNA) Treatment (Thumb Exercise, Medication, Surgery) End Users (Hospitals & Clinics, Retail Pharmacies) – Global Forecast Till 2027

ID: MRFR/MED/3800-HCR | | Region: Global | 90 pages

Please note that the assessment period of report has been updated from 2018-2025 to 2020-2027. Cordially fill the sample form for updated data

Market Scenario:


Thumb or carpometacarpal (CMC) joint arthritis is a common type of arthritis affecting the hands. In the patients with thumb arthritis, the cushion-like cartilage inside the CMC joint breaks down, causing the bones to rub against each other. Some of the common symptoms of the disease are inclusive of thumb joint pain, thumb base swelling, besides others. The prevalence of the thumb arthritis is increasing which is the major driver for the market growth. In 2016, according to a study published in the HAND (American Association for Hand Surgery) journal, the prevalence of the thumb CMC osteoarthritis was estimated to be around 8% to 12% in the general population. Moreover, growing geriatric and obese population along with the rising healthcare expenditure is estimated to boost the market growth during the forecast period. According to the World Health Organization in 2016, approximately more than 1.9 billion adults, were estimated to be overweight, accounting for 650 million obese people. Additionally, according to the World Health Organization, the world’s geriatric population is estimated to reach 2 billion by 2050 from 900 million in 2015. However, the high cost of the surgical therapeutics along with related complications is estimated to restrain the market growth during the forecast period. According to a study published in the Plastic and Reconstructive Surgery journal in 2016, the cost of therapeutic trapeziectomy with LRTI for a majority of the patients (89%) was estimated to be about around USD 2,576.


The Global Thumb Arthritis Market is expected to grow at an approximate CAGR of 8.1% during the forecast period.


Intended Audience



  • Pharmaceutical companies

  • Biotechnological institutes

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers


Figure 1:- Global thumb arthritis market share, by region

Thumb Arthritis Market


Sources: WHO, annual reports, press release, white paper, and company presentation


Segmentation


The global thumb arthritis market is segmented on the basis of type, diagnosis, treatment, and end user.


On the basis of the type, the market is segmented into osteoarthritis thumb arthritis, rheumatoid thumb arthritis, and others.


On the basis of the diagnosis, the market is segmented into physical examinations, imaging, fine needle aspiration (FNA), and others. The imaging segment is sub-segmented into X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and others.


On the basis of the treatment, the market is segmented into thumb exercise, medication, surgery, and others. The medication segment is sub-segmented into OCT medications, prescription medications, and others. The OCT medications, by treatment, is further segmented into acetaminophen, ibuprofen, and others. The prescription medications sub-segment, by treatment, is further segmented into celecoxib, meloxicam, and others. The surgery segment is sub-segmented into trapeziectomy, osteotomy, and others.


On the basis of the end users, the market is segmented into hospitals & clinics, research organizations, retail pharmacies, and others.


Key players in global thumb arthritis market


The key players in the global thumb arthritis market are inclusive of BioPro (U.S.), McKie Splints (U.S.), AbbVie Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Amgen Inc. (U.S.), Pfizer Inc. (U.S.), Carestream Health. (U.S.), General Electric Company (U.K), and others.


Research Methodology
Thumb Arthritis Market 2018


Sources: WHO, annual reports, press release, white paper, and company presentation


Regional Analysis


The Americas dominate the global thumb arthritis market owing to a well-developed healthcare sector, growing geriatric population, and rising healthcare expenditure. According to the Population Reference Bureau in 2016, the Americas’ geriatric population is estimated to be more than double from 46 million to 98 million by 2060. Moreover, the presence of the developed economies like the U.S. and Canada within the region fuels the market growth.


Europe is the second largest thumb arthritis market. Availability of the funds for research and increasing surgery adoption rates followed by the growing patient population are the major drivers of the market growth within the region. Moreover, R&D expenses in the therapeutics of the disease by the local established players are fuelling the market growth during the forecast period.


Asia Pacific is the fastest growing region owing to the growing geriatric and obese population across the globe. According to the Australian Institute of Health and Welfare in 2018, the percentage of overweight or obese adults is approximately around 53% in Northern Sydney. Moreover, it was estimated that in 2011, around 5% of the total burden of the disease accounted for the same. Additionally, the presence of the developing economies like India and China within the region with expanding healthcare sector is estimated to fuel the market growth during the forecast period.


The Middle East & Africa holds the least share in the global thumb arthritis market. This can be accounted on the basis of the poor availability of the healthcare services and low per capita healthcare expenditures within the African region. On the other hand, the Middle East is estimated to be the fastest growing region during the projected period, 2017-2023.



TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Diagnosis Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Thumb Arthritis Market, By Type

6.1 Introduction

6.2 Osteoarthritis Thumb Arthritis

Market Estimates & Forecast, 20120– 2027

6.3 Rheumatoid Thumb Arthritis

Market Estimates & Forecast, 20120– 2027

6.4 Others

Chapter 7. Global Thumb Arthritis Market, By Diagnosis

7.1 Introduction

7.2 Physical Examinations

Market Estimates & Forecast, 20120– 2027

7.3 Imaging

Market Estimates & Forecast, 20120– 2027

7.3.1 X-Ray

7.3.2 Computed Tomography (CT)

7.3.3 Magnetic Resonance Imaging (MRI)

7.3.4 Others

7.4 Fine Needle Aspiration (FNA)

Market Estimates & Forecast, 20120– 2027

7.5 Others

Chapter 8. Global Thumb Arthritis Market, By Treatment

8.1 Introduction

8.2 Thumb Exercise

Market Estimates & Forecast, 20120– 2027

8.3 Medication

Market Estimates & Forecast, 20120– 2027

8.3.1 OCT Medications

8.3.1.1 Acetaminophen

8.3.1.2 Ibuprofen

8.3.1.3 Others

8.3.2 Prescription Medications

8.3.2.1 Celecoxib

8.3.2.2 Meloxicam

8.3.2.3 Others

8.4 Surgery

8.4.1 Trapeziectomy

8.4.2 Osteotomy

8.4.3 Others

8.5 Others

Chapter 9. Global Thumb Arthritis Market, By End Users

9.1 Introduction

9.2 Hospitals & Clinics

Market Estimates & Forecast, 20120– 2027

9.3 Research Organizations

Market Estimates & Forecast, 20120– 2027

9.4 Retail Pharmacies

Market Estimates & Forecast, 20120– 2027

9.5 Others

Chapter 10. Global Thumb Arthritis Market, By Region

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K

10.3.1.6 Rest Of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic Of Korea

10.4.6 Rest Of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest Of The Middle East & Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 BioPro

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 McKie Splints

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 AbbVie Inc.

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 F. Hoffmann-La Roche Ltd

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Amgen Inc.

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial Overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Pfizer Inc.

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Carestream Health

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 General Electric Company

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs Of The Market

13.2 Key Companies To Watch

13.3 Prediction Of Thumb Arthritis Market

Chapter 14 Appendix

LIST OF TABLES

Table 1 Thumb Arthritis Industry Synopsis, 20120– 2027

Table 2 Global Thumb Arthritis Market Estimates And Forecast, 20120– 2027, (USD Million)

Table 3 Global Thumb Arthritis Market By Region, 20120– 2027, (USD Million)

Table 4 Global Thumb Arthritis Market By Type, 20120– 2027, (USD Million)

Table 5 Global Thumb Arthritis Market By Diagnosis, 20120– 2027, (USD Million)

Table 6 Global Thumb Arthritis Market By Treatment, 20120– 2027, (USD Million)

Table 7 Global Thumb Arthritis Market By End Users, 20120– 2027, (USD Million)

Table 8 North America Thumb Arthritis By Type, 20120– 2027, (USD Million)

Table 9 North America Thumb Arthritis By Diagnosis, 20120– 2027, (USD Million)

Table 10 North America Thumb Arthritis By Treatment, 20120– 2027, (USD Million)

Table 11 North America Thumb Arthritis By End Users, 20120– 2027, (USD Million)

Table 12 U.S. Thumb Arthritis By Type, 20120– 2027, (USD Million)

Table 13 U.S. Thumb Arthritis By Diagnosis, 20120– 2027, (USD Million)

Table 14 U.S. Thumb Arthritis By Treatment, 20120– 2027, (USD Million)

Table 15 U.S. Thumb Arthritis By End Users, 20120– 2027, (USD Million)

Table 16 Canada Thumb Arthritis By Type, 20120– 2027, (USD Million)

Table 17 Canada Thumb Arthritis By Diagnosis, 20120– 2027, (USD Million)

Table 18 Canada Thumb Arthritis By Treatment, 20120– 2027, (USD Million)

Table 19 Canada Thumb Arthritis By End Users, 20120– 2027, (USD Million)

Table 20 South America Thumb Arthritis By Type, 20120– 2027, (USD Million)

Table 21 South America Thumb Arthritis By Diagnosis, 20120– 2027, (USD Million)

Table 22 South America Thumb Arthritis By Treatment, 20120– 2027, (USD Million)

Table 23 South America Thumb Arthritis By End Users, 20120– 2027, (USD Million)

Table 24 Europe Thumb Arthritis By Type, 20120– 2027, (USD Million)

Table 25 Europe Thumb Arthritis By Diagnosis, 20120– 2027, (USD Million)

Table 26 Europe Thumb Arthritis By Treatment, 20120– 2027, (USD Million)

Table 27 Europe Thumb Arthritis By End Users, 20120– 2027, (USD Million)

Table 28 Western Europe Thumb Arthritis By Type, 20120– 2027, (USD Million)

Table 29 Western Europe Thumb Arthritis By Diagnosis, 20120– 2027, (USD Million)

Table 30 Western Europe Thumb Arthritis By Treatment, 20120– 2027, (USD Million)

Table 31 Western Europe Thumb Arthritis By End Users, 20120– 2027, (USD Million)

Table 32 Eastern Europe Thumb Arthritis By Type, 20120– 2027, (USD Million)

Table 33 Eastern Europe Thumb Arthritis By Diagnosis, 20120– 2027, (USD Million)

Table 34 Eastern Europe Thumb Arthritis By Treatment, 20120– 2027, (USD Million)

Table 35 Eastern Europe Thumb Arthritis By End Users, 20120– 2027, (USD Million)

Table 36 Asia Pacific Thumb Arthritis By Type, 20120– 2027, (USD Million)

Table 37 Asia Pacific Thumb Arthritis By Diagnosis, 20120– 2027, (USD Million)

Table 38 Asia Pacific Thumb Arthritis By Treatment, 20120– 2027, (USD Million)

Table 39 Asia Pacific Thumb Arthritis By End Users, 20120– 2027, (USD Million)

Table 40 Middle East & Africa Thumb Arthritis By Type, 20120– 2027, (USD Million)

Table 41 Middle East & Africa Thumb Arthritis By Diagnosis, 20120– 2027, (USD Million)

Table 42 Middle East & Africa Thumb Arthritis By Treatment, 20120– 2027, (USD Million)

Table 43 Middle East & Africa Thumb Arthritis By End Users, 20120– 2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Thumb Arthritis Market

Figure 3 Market Dynamics For Global Thumb Arthritis Market

Figure 4 Global Thumb Arthritis Market Share, By Type 2020

Figure 5 Global Thumb Arthritis Market Share, By Diagnosis 2020

Figure 6 Global Thumb Arthritis Market Share, By Treatment, 2020

Figure 7 Global Thumb Arthritis Market Share, By End Users, 2020

Figure 8 Global Thumb Arthritis Market Share, By Region, 2020

Figure 9 North America Thumb Arthritis Share, By Country, 2020

Figure 10 Europe Thumb Arthritis Share, By Country, 2020

Figure 11 Asia Pacific Thumb Arthritis Share, By Country, 2020

Figure 12 Middle East & Africa Thumb Arthritis Share, By Country, 2020

Figure 13 Global Thumb Arthritis Market: Company Share Analysis, 2020 (%)

Figure 14 BioPro: Key Financials

Figure 15 BioPro: Segmental Revenue

Figure 16 BioPro: Geographical Revenue

Figure 17 McKie Splints: Type UK Ltd: Key Financials

Figure 18 McKie Splints: Type UK Ltd: Segmental Revenue

Figure 19 McKie Splints: Type UK Ltd: Geographical Revenue

Figure 20 AbbVie Inc.: Key Financials

Figure 21 AbbVie Inc.: Segmental Revenue

Figure 22 AbbVie Inc.: Geographical Revenue

Figure 23 F. Hoffmann-La Roche Ltd: Key Financials

Figure 24 F. Hoffmann-La Roche Ltd: Segmental Revenue

Figure 25 F. Hoffmann-La Roche Ltd: Geographical Revenue

Figure 26 Amgen Inc.: Key Financials

Figure 27 Amgen Inc.: Segmental Revenue

Figure 28 Amgen Inc.: Geographical Revenue

Figure 29 Pfizer Inc.: Key Financials

Figure 30 Pfizer Inc.: Segmental Revenue

Figure 31 Pfizer Inc.: Geographical Revenue

Figure 32 Carestream Health: Key Financials

Figure 33 Carestream Health: Segmental Revenue

Figure 34 Carestream Health: Geographical Revenue

Figure 35 General Electric Company: Key Financials

Figure 36 General Electric Company: Segmental Revenue

Figure 37 General Electric Company: Geographical Revenue